ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $49,382,000 | +15829.7% | 2,618,371 | +9844.1% | 1.70% | +18733.3% |
| Q2 2019 | $310,000 | +66.7% | 26,331 | +44.8% | 0.01% | +125.0% |
| Q4 2018 | $186,000 | -67.8% | 18,184 | -47.6% | 0.00% | -73.3% |
| Q3 2018 | $578,000 | +204.2% | 34,717 | +189.0% | 0.02% | +114.3% |
| Q2 2018 | $190,000 | -86.1% | 12,013 | -89.2% | 0.01% | -80.0% |
| Q3 2017 | $1,367,000 | +147.2% | 111,615 | +131.1% | 0.04% | +105.9% |
| Q2 2017 | $553,000 | -6.3% | 48,304 | +168.1% | 0.02% | -15.0% |
| Q3 2015 | $590,000 | -14.2% | 18,017 | +38.8% | 0.02% | 0.0% |
| Q2 2015 | $688,000 | +170.9% | 12,982 | +47.3% | 0.02% | +150.0% |
| Q1 2015 | $254,000 | – | 8,816 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |